
More recent developments

Quick Take: Washington’s fear of Chinese biotech could be just what Beijing needs
The Trump administration is considering an executive order (E.O.) that would block US pharma companies from buying Chinese-developed drug candidates. Per the New York Times: “At the heart of the possible clampdown is a drafted executive order that threatens to… Read More »

Deep Dive: The AI Plus plan – China’s blueprint for AI diffusion
On August 26, the State Council published a high-level directive on implementing the AI Plus policy initiative. This document is a big deal: It represents China's most detailed plan to date addressing how the country intends to develop and diffuse… Read More »

Quick take: DeepSeek struggles to train models on Huawei
What happened: On August 14, the FT reported that the launch of DeepSeek's R2 model has been delayed due to difficulties getting Huawei’s Ascend AI chips working for model training. The company has switched back to Nvidia for training, but… Read More »